Literature DB >> 15616877

Chemoradiotherapy for brain tumors: current status and perspectives.

Masao Matsutani1.   

Abstract

Brain tumors growing in the parenchyma of the brain infiltrate diffusely, and the role of surgery is restricted to maximal tumor-bulk removal. Residual tumor cells beyond the surgical margin are not killed by conventional radiation therapy with 60 'Gy. Many clinical trials delivering chemotherapy during radiation therapy and after radiation therapy have been performed, but the results remain poor. Here the author reviews the current treatments of gliomas, malignant lymphomas, medulloblastomas, and germ cell tumors, and their results.

Entities:  

Mesh：

Year:  2004        PMID： 15616877     DOI： 10.1007/s10147-004-0456-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  9 in total

1.  Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.

Authors:  Chaim B Colen; Navid Seraji-Bozorgzad; Brian Marples; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neurosurgery       Date:  2006-12       Impact factor: 4.654

2.  Medulloblastoma in children: a 32-year experience from a single institution.

Authors:  Canan Akyüz; Ali Varan; Serhan Küpeli; Nejat Akalan; Figen Söylemezoglu; Faruk Zorlu; Tezer Kutluk; Münevver Büyükpamukçu
Journal:  J Neurooncol       Date:  2008-06-20       Impact factor: 4.130

Review 3.  Medulloblastoma: from molecular pathology to therapy.

Authors:  Alessandra Rossi; Valentina Caracciolo; Giuseppe Russo; Krzysztof Reiss; Antonio Giordano
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

4.  The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.

Authors:  Alessandra Rossi; Giuseppe Russo; Andrew Puca; Raffaele La Montagna; Mariella Caputo; Eliseo Mattioli; Massimo Lopez; Antonio Giordano; Francesca Pentimalli
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

Review 5.  The adolescent and young adult with cancer: state of the art--brain tumor.

Authors:  Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 6.  Heme Oxygenase-1 in Central Nervous System Malignancies.

Authors:  Giuseppe Sferrazzo; Michelino Di Rosa; Eugenio Barone; Giovanni Li Volti; Nicolò Musso; Daniele Tibullo; Ignazio Barbagallo
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

7.  Adult medulloblastoma associated with syringomyelia: a case report.

Authors:  Ching-Chun Wang
Journal:  Cancer Biol Med       Date:  2012-06       Impact factor: 4.248

8.  Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood.

Authors:  Emi Hirano; Hiroshi Fuji; Tsuyoshi Onoe; Vinay Kumar; Hiroki Shirato; Koichi Kawabuchi
Journal:  J Radiat Res       Date:  2013-11-01       Impact factor: 2.724

9.  Implantable NMR Microcoils in Rats: A New Tool for Exploring Tumor Metabolism at Sub-Microliter Scale?

Authors:  Justine Deborne; Noël Pinaud; Yannick Crémillieux
Journal:  Metabolites       Date:  2021-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.